Ben-Quan Shen - Senior Fellow, Senior Director and Group Head, Translational PKPD, Development Sciences

Ben-Quan Shen

Senior Fellow, Senior Director and Group Head, Translational PKPD, Development Sciences

Fellow
"Genentech's stimulating environment and opportunities to advance my career really attracted me here. I'm so excited to work with so many of the brightest and most innovative scientists to develop new treatments for some of the most difficult-to-treat diseases - all while positioning myself for personal success and staying competitive at the forefront of medical technology."
28
Years at Genentech
44
Publications at Genentech
2
Awards & Honors

I received a Medical Degree from Nanjing Medical Univ. China in 1983 and then conducted my postdoctoral training at UCSF before joining Genentech in 1996.

Over my tenure at Genentech, I have served as a key scientific and strategic leader, driving the investigative PKPD effort in support of discovery and development of protein therapeutics.

I also identify and investigate key scientific issues related to the ADME and PKPD of exciting and novel drug candidates in the areas of BioOncology, Immunology, and Infectious Disease areas. I am responsible for developing novel scientific tools to understand factors that affect the disposition of biologics and leverage it for the selection and development of therapeutic candidates.

Featured Publication

A novel approach to quantitate biodistribution and transduction of adeno-associated virus gene therapy using radiolabeled AAV vectors in mice.

Mol Ther Methods Clin Dev. 2024

Hongzhi Wang, Ran Li, Shraddha Sadekar, Amrita Kamath, and Ben-Quan Shen*.

Preclinical Characterization of the Distribution, Catabolism and Elimination of Polatuzumab Vedotin-piiq (POLIVY®) Antibody-Drug Conjugate in Sprague Dawley Rats.

Journal of Clinical Medicine. 2021

Victor Yip, M. Violet Lee, Sylvia Wong, Ola Saad, Shuguang Ma, S. Cyrus Khojasteh, and Ben-Quan Shen*.

Anti-Lymphocyte Antigen 6 Complex, Locus E- Seco-Cyclopropabenzindol-4-One-Dimer Antibody-Drug Conjugate That Forms Adduct with α 1-Microglobulin Demonstrates Slower Systemic Antibody Clearance and Reduced Tumor Distribution in Animals.

Drug Metab. Dispos. 2020

Victor Yip, Isabel Figueroa, Brandon Latifi, Shab Masih, Carl Ng, Doug Leipold, Amrita Kamath, and Ben-Quan Shen*.

Characterization of Tissue Distribution, Catabolism and Elimination of an Anti-Staphylococcus aureus THIOMABTM Antibody-Antibiotic Conjugate in Rats.

Drug Metab. Dispos. 2020

Hao Cai, Victor Yip, M. Violet Lee, Sylvia Wong, Ola Saad, Shuguang Ma, Nina Ljumanovic, S. Cyrus Khojasteh, Amrita V. Kamath, and Ben-Quan Shen*.

Impact of conjugation site on ADC stability and biological activity.

Nature Biotechnology. 2012 (*Received 2015 World ADC Conference Best Publication Award 2010-2015; Highlighted in Nature Biotech 20 years Special Issue due to its impact on the ADC field over the past 20 years)

Ben-Quan Shen*, Keyang Xu*, …. and Junutula. J.R.